Viewing Study NCT00831766

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 4:44 PM
Ignite Modification Date: 2026-01-25 @ 12:47 AM
Study NCT ID: NCT00831766
Status: COMPLETED
Last Update Posted: 2020-12-22
First Post: 2009-01-28
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Idarubicin + Cytarabine and Lenalidomide in Patients With Myelodysplastic Syndrome (MDS), Acute Myeloid Leukemia (AML)
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Myelodysplastic Syndrome View
None Acute Myeloid Leukemia View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Hematopoietic View
None Myeloid and Monocytic Leukemia View
None AML View